Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EZH2
|
ENSG00000106462.6 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EZH2 | hg19_v2_chr7_-_148581251_148581347 | -0.49 | 5.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_205391178 | 3.47 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
chr7_-_41740181 | 3.43 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
chr8_-_7274385 | 2.72 |
ENST00000318157.2
|
DEFB4B
|
defensin, beta 4B |
chr3_-_195538728 | 2.54 |
ENST00000349607.4
ENST00000346145.4 |
MUC4
|
mucin 4, cell surface associated |
chr19_-_51456344 | 2.51 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr19_-_51504852 | 2.49 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
chr12_-_91576561 | 2.21 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
chr19_+_51152702 | 2.19 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
chr3_-_195538760 | 2.10 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
chr13_-_20805109 | 2.04 |
ENST00000241124.6
|
GJB6
|
gap junction protein, beta 6, 30kDa |
chr1_+_152881014 | 2.02 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
chr1_-_145076186 | 1.95 |
ENST00000369348.3
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
chr5_+_92919043 | 1.85 |
ENST00000327111.3
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1 |
chr11_-_66496430 | 1.85 |
ENST00000533211.1
|
SPTBN2
|
spectrin, beta, non-erythrocytic 2 |
chr10_-_105845674 | 1.79 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
chr2_-_31637560 | 1.79 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
chr7_+_145813453 | 1.74 |
ENST00000361727.3
|
CNTNAP2
|
contactin associated protein-like 2 |
chr4_+_156588249 | 1.68 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr20_-_55100981 | 1.66 |
ENST00000243913.4
|
GCNT7
|
glucosaminyl (N-acetyl) transferase family member 7 |
chr15_+_63335899 | 1.65 |
ENST00000561266.1
|
TPM1
|
tropomyosin 1 (alpha) |
chr12_-_91576429 | 1.63 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
chr17_+_34538310 | 1.61 |
ENST00000444414.1
ENST00000378350.4 ENST00000389068.5 ENST00000588929.1 ENST00000589079.1 ENST00000589336.1 ENST00000400702.4 ENST00000591167.1 ENST00000586598.1 ENST00000591637.1 ENST00000378352.4 ENST00000358756.5 |
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1 |
chr17_+_34639793 | 1.58 |
ENST00000394465.2
ENST00000394463.2 ENST00000378342.4 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
chr15_-_89764929 | 1.57 |
ENST00000268125.5
|
RLBP1
|
retinaldehyde binding protein 1 |
chr2_+_45168875 | 1.57 |
ENST00000260653.3
|
SIX3
|
SIX homeobox 3 |
chr14_+_79745746 | 1.52 |
ENST00000281127.7
|
NRXN3
|
neurexin 3 |
chr1_+_86889769 | 1.52 |
ENST00000370565.4
|
CLCA2
|
chloride channel accessory 2 |
chr12_-_91576750 | 1.50 |
ENST00000228329.5
ENST00000303320.3 ENST00000052754.5 |
DCN
|
decorin |
chr1_+_47264711 | 1.49 |
ENST00000371923.4
ENST00000271153.4 ENST00000371919.4 |
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1 |
chr17_+_34640031 | 1.46 |
ENST00000339270.6
ENST00000482104.1 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
chr8_+_102504651 | 1.45 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
chr5_-_149669192 | 1.40 |
ENST00000398376.3
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha |
chr7_-_121944491 | 1.38 |
ENST00000331178.4
ENST00000427185.2 ENST00000442488.2 |
FEZF1
|
FEZ family zinc finger 1 |
chr4_-_16900242 | 1.38 |
ENST00000502640.1
ENST00000506732.1 |
LDB2
|
LIM domain binding 2 |
chr20_-_42815733 | 1.31 |
ENST00000342272.3
|
JPH2
|
junctophilin 2 |
chr1_-_205419053 | 1.29 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
chr7_+_80275621 | 1.28 |
ENST00000426978.1
ENST00000432207.1 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr4_-_47983519 | 1.27 |
ENST00000358519.4
ENST00000544810.1 ENST00000402813.3 |
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
chr4_+_156588115 | 1.26 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr14_-_81408063 | 1.25 |
ENST00000557411.1
|
CEP128
|
centrosomal protein 128kDa |
chr4_-_16900217 | 1.23 |
ENST00000441778.2
|
LDB2
|
LIM domain binding 2 |
chr2_+_90108504 | 1.22 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr2_-_113594279 | 1.21 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr20_-_656437 | 1.19 |
ENST00000488788.2
|
RP5-850E9.3
|
Uncharacterized protein |
chr14_+_79746249 | 1.16 |
ENST00000428277.2
|
NRXN3
|
neurexin 3 |
chr2_-_216003127 | 1.16 |
ENST00000412081.1
ENST00000272895.7 |
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12 |
chr4_-_80994619 | 1.15 |
ENST00000404191.1
|
ANTXR2
|
anthrax toxin receptor 2 |
chr3_+_47324424 | 1.14 |
ENST00000437353.1
ENST00000232766.5 ENST00000455924.2 |
KLHL18
|
kelch-like family member 18 |
chr1_+_117544366 | 1.13 |
ENST00000256652.4
ENST00000369470.1 |
CD101
|
CD101 molecule |
chr15_+_59903975 | 1.12 |
ENST00000560585.1
ENST00000396065.1 |
GCNT3
|
glucosaminyl (N-acetyl) transferase 3, mucin type |
chr4_-_80994471 | 1.11 |
ENST00000295465.4
|
ANTXR2
|
anthrax toxin receptor 2 |
chr4_-_159094194 | 1.05 |
ENST00000592057.1
ENST00000585682.1 ENST00000393807.5 |
FAM198B
|
family with sequence similarity 198, member B |
chr3_-_131753830 | 1.05 |
ENST00000429747.1
|
CPNE4
|
copine IV |
chr17_-_40575535 | 1.04 |
ENST00000357037.5
|
PTRF
|
polymerase I and transcript release factor |
chr4_-_16900184 | 1.03 |
ENST00000515064.1
|
LDB2
|
LIM domain binding 2 |
chr20_+_62669472 | 1.03 |
ENST00000463337.1
ENST00000358393.1 |
LINC00176
|
long intergenic non-protein coding RNA 176 |
chr2_-_89459813 | 1.00 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr4_-_16900410 | 0.99 |
ENST00000304523.5
|
LDB2
|
LIM domain binding 2 |
chr5_+_175298487 | 0.99 |
ENST00000393745.3
|
CPLX2
|
complexin 2 |
chr1_+_171154347 | 0.99 |
ENST00000209929.7
ENST00000441535.1 |
FMO2
|
flavin containing monooxygenase 2 (non-functional) |
chr2_+_90060377 | 0.95 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr14_+_23305760 | 0.95 |
ENST00000311852.6
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted) |
chr12_+_66217911 | 0.95 |
ENST00000403681.2
|
HMGA2
|
high mobility group AT-hook 2 |
chr6_-_32145861 | 0.93 |
ENST00000336984.6
|
AGPAT1
|
1-acylglycerol-3-phosphate O-acyltransferase 1 |
chr3_+_186915274 | 0.93 |
ENST00000312295.4
|
RTP1
|
receptor (chemosensory) transporter protein 1 |
chr19_-_51456321 | 0.93 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr2_+_33172221 | 0.93 |
ENST00000354476.3
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr11_+_64004888 | 0.92 |
ENST00000541681.1
|
VEGFB
|
vascular endothelial growth factor B |
chr3_-_124839648 | 0.92 |
ENST00000430155.2
|
SLC12A8
|
solute carrier family 12, member 8 |
chr4_+_74269956 | 0.90 |
ENST00000295897.4
ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB
|
albumin |
chr1_+_63063152 | 0.89 |
ENST00000371129.3
|
ANGPTL3
|
angiopoietin-like 3 |
chr5_-_147162078 | 0.87 |
ENST00000507386.1
|
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chr2_-_190044480 | 0.87 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr7_-_100808843 | 0.86 |
ENST00000249330.2
|
VGF
|
VGF nerve growth factor inducible |
chr18_+_29027696 | 0.85 |
ENST00000257189.4
|
DSG3
|
desmoglein 3 |
chr6_-_134639180 | 0.85 |
ENST00000367858.5
|
SGK1
|
serum/glucocorticoid regulated kinase 1 |
chr15_-_90222642 | 0.84 |
ENST00000430628.2
|
PLIN1
|
perilipin 1 |
chr10_-_100995540 | 0.83 |
ENST00000370546.1
ENST00000404542.1 |
HPSE2
|
heparanase 2 |
chrX_-_24665208 | 0.83 |
ENST00000356768.4
|
PCYT1B
|
phosphate cytidylyltransferase 1, choline, beta |
chr11_-_111781610 | 0.83 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr15_-_90222610 | 0.83 |
ENST00000300055.5
|
PLIN1
|
perilipin 1 |
chr1_+_207039154 | 0.82 |
ENST00000367096.3
ENST00000391930.2 |
IL20
|
interleukin 20 |
chr5_-_35195338 | 0.82 |
ENST00000509839.1
|
PRLR
|
prolactin receptor |
chrX_+_99899180 | 0.82 |
ENST00000373004.3
|
SRPX2
|
sushi-repeat containing protein, X-linked 2 |
chr11_+_130318869 | 0.81 |
ENST00000299164.2
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
chr11_+_111126707 | 0.80 |
ENST00000280325.4
|
C11orf53
|
chromosome 11 open reading frame 53 |
chr6_-_47009996 | 0.80 |
ENST00000371243.2
|
GPR110
|
G protein-coupled receptor 110 |
chr14_+_60975644 | 0.80 |
ENST00000327720.5
|
SIX6
|
SIX homeobox 6 |
chr6_-_31550192 | 0.80 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr6_-_51952418 | 0.80 |
ENST00000371117.3
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive) |
chr14_+_22580233 | 0.79 |
ENST00000390454.2
|
TRAV25
|
T cell receptor alpha variable 25 |
chr19_+_35645618 | 0.79 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr1_+_161195781 | 0.78 |
ENST00000367988.3
|
TOMM40L
|
translocase of outer mitochondrial membrane 40 homolog (yeast)-like |
chr4_-_76928641 | 0.78 |
ENST00000264888.5
|
CXCL9
|
chemokine (C-X-C motif) ligand 9 |
chr6_-_131277510 | 0.78 |
ENST00000525193.1
ENST00000527659.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chrX_-_153599578 | 0.78 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
chr4_+_156587979 | 0.77 |
ENST00000511507.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr17_+_4736627 | 0.77 |
ENST00000355280.6
ENST00000347992.7 |
MINK1
|
misshapen-like kinase 1 |
chr3_-_187009646 | 0.76 |
ENST00000296280.6
ENST00000392470.2 ENST00000169293.6 ENST00000439271.1 ENST00000392472.2 ENST00000392475.2 |
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
chr2_-_24308051 | 0.76 |
ENST00000238721.4
ENST00000335934.4 |
TP53I3
|
tumor protein p53 inducible protein 3 |
chr7_-_99774945 | 0.76 |
ENST00000292377.2
|
GPC2
|
glypican 2 |
chr1_+_32687971 | 0.75 |
ENST00000373586.1
|
EIF3I
|
eukaryotic translation initiation factor 3, subunit I |
chrX_+_41192595 | 0.75 |
ENST00000399959.2
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
chr6_+_46620705 | 0.74 |
ENST00000452689.2
|
SLC25A27
|
solute carrier family 25, member 27 |
chr16_-_29910853 | 0.74 |
ENST00000308713.5
|
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
chr17_-_60885700 | 0.74 |
ENST00000583600.1
|
MARCH10
|
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
chr5_-_147162263 | 0.73 |
ENST00000333010.6
ENST00000265272.5 |
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chr11_+_111169565 | 0.73 |
ENST00000528846.1
|
COLCA2
|
colorectal cancer associated 2 |
chr19_-_43702231 | 0.73 |
ENST00000597374.1
ENST00000599371.1 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
chr1_+_207038699 | 0.72 |
ENST00000367098.1
|
IL20
|
interleukin 20 |
chrX_-_138724677 | 0.71 |
ENST00000370573.4
ENST00000338585.6 ENST00000370576.4 |
MCF2
|
MCF.2 cell line derived transforming sequence |
chr11_-_111782484 | 0.71 |
ENST00000533971.1
|
CRYAB
|
crystallin, alpha B |
chr16_+_70680439 | 0.70 |
ENST00000288098.2
|
IL34
|
interleukin 34 |
chr14_+_24540731 | 0.70 |
ENST00000558859.1
ENST00000559197.1 ENST00000560828.1 ENST00000216775.2 ENST00000560884.1 |
CPNE6
|
copine VI (neuronal) |
chr8_+_128748308 | 0.70 |
ENST00000377970.2
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog |
chr20_+_62795827 | 0.69 |
ENST00000328439.1
ENST00000536311.1 |
MYT1
|
myelin transcription factor 1 |
chr17_+_7387919 | 0.69 |
ENST00000572844.1
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
chr20_+_49126881 | 0.69 |
ENST00000371621.3
ENST00000541713.1 |
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1 |
chr11_+_57105991 | 0.68 |
ENST00000263314.2
|
P2RX3
|
purinergic receptor P2X, ligand-gated ion channel, 3 |
chr12_-_13248598 | 0.68 |
ENST00000337630.6
ENST00000545699.1 |
GSG1
|
germ cell associated 1 |
chr3_-_195310802 | 0.68 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
chr18_+_49866496 | 0.68 |
ENST00000442544.2
|
DCC
|
deleted in colorectal carcinoma |
chr12_-_118406777 | 0.68 |
ENST00000339824.5
|
KSR2
|
kinase suppressor of ras 2 |
chr19_+_41869894 | 0.68 |
ENST00000413014.2
|
TMEM91
|
transmembrane protein 91 |
chr11_-_3692597 | 0.68 |
ENST00000534359.1
ENST00000250699.2 |
CHRNA10
|
cholinergic receptor, nicotinic, alpha 10 (neuronal) |
chrX_+_122318006 | 0.68 |
ENST00000371266.1
ENST00000264357.5 |
GRIA3
|
glutamate receptor, ionotropic, AMPA 3 |
chr17_-_8055747 | 0.67 |
ENST00000317276.4
ENST00000581703.1 |
PER1
|
period circadian clock 1 |
chrX_-_131623982 | 0.67 |
ENST00000370844.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
chr6_+_25279651 | 0.66 |
ENST00000329474.6
|
LRRC16A
|
leucine rich repeat containing 16A |
chr18_+_50278430 | 0.65 |
ENST00000578080.1
ENST00000582875.1 ENST00000412726.1 |
DCC
|
deleted in colorectal carcinoma |
chr1_-_154943212 | 0.65 |
ENST00000368445.5
ENST00000448116.2 ENST00000368449.4 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
chr19_-_51141196 | 0.65 |
ENST00000338916.4
|
SYT3
|
synaptotagmin III |
chr2_+_33359687 | 0.65 |
ENST00000402934.1
ENST00000404525.1 ENST00000407925.1 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr17_-_60885659 | 0.65 |
ENST00000311269.5
|
MARCH10
|
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
chr18_-_56296182 | 0.65 |
ENST00000361673.3
|
ALPK2
|
alpha-kinase 2 |
chr11_-_111781454 | 0.65 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chr2_-_114036488 | 0.65 |
ENST00000263335.7
ENST00000397647.3 ENST00000348715.5 ENST00000429538.3 |
PAX8
|
paired box 8 |
chr1_-_154943002 | 0.64 |
ENST00000606391.1
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
chr15_-_43910438 | 0.64 |
ENST00000432436.1
|
STRC
|
stereocilin |
chr12_+_56414851 | 0.64 |
ENST00000547167.1
|
IKZF4
|
IKAROS family zinc finger 4 (Eos) |
chr16_+_30773636 | 0.64 |
ENST00000402121.3
ENST00000565995.1 ENST00000563683.1 ENST00000357890.5 ENST00000565931.1 |
RNF40
|
ring finger protein 40, E3 ubiquitin protein ligase |
chr18_-_35145981 | 0.63 |
ENST00000420428.2
ENST00000412753.1 |
CELF4
|
CUGBP, Elav-like family member 4 |
chr11_-_123065989 | 0.63 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
chr17_-_72358001 | 0.63 |
ENST00000375366.3
|
BTBD17
|
BTB (POZ) domain containing 17 |
chr7_-_129251459 | 0.63 |
ENST00000608694.1
|
RP11-448A19.1
|
RP11-448A19.1 |
chr19_-_36019123 | 0.63 |
ENST00000588674.1
ENST00000452271.2 ENST00000518157.1 |
SBSN
|
suprabasin |
chr11_-_66675371 | 0.63 |
ENST00000393955.2
|
PC
|
pyruvate carboxylase |
chr1_-_205904950 | 0.62 |
ENST00000340781.4
|
SLC26A9
|
solute carrier family 26 (anion exchanger), member 9 |
chr19_-_35625765 | 0.62 |
ENST00000591633.1
|
LGI4
|
leucine-rich repeat LGI family, member 4 |
chr19_+_35783047 | 0.62 |
ENST00000595791.1
ENST00000597035.1 ENST00000537831.2 |
MAG
|
myelin associated glycoprotein |
chr15_+_75105170 | 0.62 |
ENST00000379709.3
|
LMAN1L
|
lectin, mannose-binding, 1 like |
chr15_+_63414017 | 0.61 |
ENST00000413507.2
|
LACTB
|
lactamase, beta |
chr12_-_115121962 | 0.61 |
ENST00000349155.2
|
TBX3
|
T-box 3 |
chr5_-_11588907 | 0.61 |
ENST00000513598.1
ENST00000503622.1 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
chr8_+_128748466 | 0.60 |
ENST00000524013.1
ENST00000520751.1 |
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog |
chr14_-_65409438 | 0.60 |
ENST00000557049.1
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal) |
chr7_+_134576317 | 0.59 |
ENST00000424922.1
ENST00000495522.1 |
CALD1
|
caldesmon 1 |
chr10_+_75670862 | 0.59 |
ENST00000446342.1
ENST00000372764.3 ENST00000372762.4 |
PLAU
|
plasminogen activator, urokinase |
chr5_-_177423243 | 0.59 |
ENST00000308304.2
|
PROP1
|
PROP paired-like homeobox 1 |
chr6_-_75915757 | 0.59 |
ENST00000322507.8
|
COL12A1
|
collagen, type XII, alpha 1 |
chr2_-_89327228 | 0.59 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr4_+_156588350 | 0.59 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr7_-_155604967 | 0.58 |
ENST00000297261.2
|
SHH
|
sonic hedgehog |
chr20_+_16729003 | 0.58 |
ENST00000246081.2
|
OTOR
|
otoraplin |
chr6_+_146350267 | 0.58 |
ENST00000355289.4
ENST00000282753.1 |
GRM1
|
glutamate receptor, metabotropic 1 |
chr4_+_123747834 | 0.58 |
ENST00000264498.3
|
FGF2
|
fibroblast growth factor 2 (basic) |
chrX_-_48815633 | 0.57 |
ENST00000428668.2
|
OTUD5
|
OTU domain containing 5 |
chr4_-_153457197 | 0.57 |
ENST00000281708.4
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr6_+_12290586 | 0.57 |
ENST00000379375.5
|
EDN1
|
endothelin 1 |
chr1_-_167059830 | 0.57 |
ENST00000367868.3
|
GPA33
|
glycoprotein A33 (transmembrane) |
chr2_+_210288760 | 0.56 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
chr17_+_7387677 | 0.56 |
ENST00000322644.6
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
chr14_+_22337014 | 0.56 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
chr16_-_11367452 | 0.56 |
ENST00000327157.2
|
PRM3
|
protamine 3 |
chr12_-_6483969 | 0.56 |
ENST00000396966.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chrX_+_122318224 | 0.56 |
ENST00000542149.1
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3 |
chr2_+_210444748 | 0.56 |
ENST00000392194.1
|
MAP2
|
microtubule-associated protein 2 |
chr12_+_101988774 | 0.56 |
ENST00000545503.2
ENST00000536007.1 ENST00000541119.1 ENST00000361466.2 ENST00000551300.1 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr2_+_220325441 | 0.56 |
ENST00000396688.1
|
SPEG
|
SPEG complex locus |
chr15_-_77988485 | 0.56 |
ENST00000561030.1
|
LINGO1
|
leucine rich repeat and Ig domain containing 1 |
chr10_-_100995603 | 0.55 |
ENST00000370552.3
ENST00000370549.1 |
HPSE2
|
heparanase 2 |
chr4_+_88720698 | 0.55 |
ENST00000226284.5
|
IBSP
|
integrin-binding sialoprotein |
chr8_+_85618155 | 0.54 |
ENST00000523850.1
ENST00000521376.1 |
RALYL
|
RALY RNA binding protein-like |
chr7_+_150688166 | 0.54 |
ENST00000461406.1
|
NOS3
|
nitric oxide synthase 3 (endothelial cell) |
chr13_+_78109884 | 0.53 |
ENST00000377246.3
ENST00000349847.3 |
SCEL
|
sciellin |
chr3_+_197677047 | 0.53 |
ENST00000448864.1
|
RPL35A
|
ribosomal protein L35a |
chr1_-_38230738 | 0.53 |
ENST00000427468.2
ENST00000373048.4 ENST00000319637.6 |
EPHA10
|
EPH receptor A10 |
chr5_-_11589131 | 0.53 |
ENST00000511377.1
|
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
chr2_+_114195268 | 0.53 |
ENST00000259199.4
ENST00000416503.2 ENST00000433343.2 |
CBWD2
|
COBW domain containing 2 |
chr17_+_43318434 | 0.53 |
ENST00000587489.1
|
FMNL1
|
formin-like 1 |
chr12_+_101988627 | 0.53 |
ENST00000547405.1
ENST00000452455.2 ENST00000441232.1 ENST00000360610.2 ENST00000392934.3 ENST00000547509.1 ENST00000361685.2 ENST00000549145.1 ENST00000553190.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr1_-_161193349 | 0.53 |
ENST00000469730.2
ENST00000463273.1 ENST00000464492.1 ENST00000367990.3 ENST00000470459.2 ENST00000468465.1 ENST00000463812.1 |
APOA2
|
apolipoprotein A-II |
chr9_+_34989638 | 0.52 |
ENST00000453597.3
ENST00000335998.3 ENST00000312316.5 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr4_+_155484155 | 0.52 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
chr13_+_78109804 | 0.52 |
ENST00000535157.1
|
SCEL
|
sciellin |
chr11_-_111781554 | 0.51 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr6_-_41863098 | 0.51 |
ENST00000373006.1
|
USP49
|
ubiquitin specific peptidase 49 |
chr3_+_42190714 | 0.51 |
ENST00000449246.1
|
TRAK1
|
trafficking protein, kinesin binding 1 |
chr15_+_78730622 | 0.51 |
ENST00000560440.1
|
IREB2
|
iron-responsive element binding protein 2 |
chrX_+_28605516 | 0.50 |
ENST00000378993.1
|
IL1RAPL1
|
interleukin 1 receptor accessory protein-like 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.7 | 4.3 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.7 | 2.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.7 | 2.0 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.6 | 1.7 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.6 | 3.4 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.5 | 1.5 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.5 | 7.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 1.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.4 | 1.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 1.3 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.4 | 0.4 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.4 | 2.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 1.0 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.3 | 0.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.3 | 1.2 | GO:0031049 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.3 | 0.9 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.3 | 1.5 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 0.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 0.6 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.3 | 0.6 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 0.8 | GO:0060067 | cervix development(GO:0060067) |
0.3 | 1.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 1.1 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.3 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 0.8 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.3 | 0.8 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.2 | 8.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 1.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 1.3 | GO:2000332 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.2 | 0.6 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.2 | 1.7 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 2.1 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 0.6 | GO:0060931 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.2 | 0.6 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.2 | 0.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 1.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.4 | GO:0032499 | detection of peptidoglycan(GO:0032499) |
0.2 | 0.6 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.9 | GO:1990834 | response to odorant(GO:1990834) |
0.2 | 1.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.4 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.2 | 0.9 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.2 | 0.5 | GO:0014806 | negative regulation of muscle hyperplasia(GO:0014740) smooth muscle hyperplasia(GO:0014806) |
0.2 | 0.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.2 | 0.5 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.2 | 0.5 | GO:0060621 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.2 | 0.3 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.2 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.6 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 0.5 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.2 | 1.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.6 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.4 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 1.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.4 | GO:0021569 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 2.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.8 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 1.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 1.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 1.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.8 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 1.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 1.9 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.4 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 0.5 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.1 | 4.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.3 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 0.2 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 1.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 0.5 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.1 | 0.7 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.4 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.4 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.1 | 0.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.3 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.1 | 0.3 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.1 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.6 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.7 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.8 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.5 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 1.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.2 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 0.3 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.1 | 0.8 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 1.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.1 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
0.1 | 0.3 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 1.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.6 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.8 | GO:1903944 | negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 1.5 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.5 | GO:1904044 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) response to aldosterone(GO:1904044) |
0.1 | 0.6 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 1.0 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 1.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 0.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 1.0 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.1 | 0.6 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.1 | 0.3 | GO:2001191 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
0.1 | 0.2 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.2 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.1 | 1.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.8 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.2 | GO:1905154 | negative regulation of eosinophil activation(GO:1902567) negative regulation of membrane invagination(GO:1905154) negative regulation of eosinophil migration(GO:2000417) |
0.1 | 0.2 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.1 | 0.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:1904000 | positive regulation of eating behavior(GO:1904000) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) regulation of small intestine smooth muscle contraction(GO:1904347) positive regulation of small intestine smooth muscle contraction(GO:1904349) small intestine smooth muscle contraction(GO:1990770) negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.3 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 0.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.5 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.2 | GO:0045659 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.1 | 0.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.5 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.3 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 0.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 1.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 2.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.2 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.5 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.2 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.2 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.0 | 0.1 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.0 | 1.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.4 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.0 | 0.1 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.0 | 0.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.3 | GO:0021575 | hindbrain morphogenesis(GO:0021575) |
0.0 | 0.1 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.0 | 0.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.0 | 2.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.3 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.3 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.0 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.2 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 2.1 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0035054 | septum secundum development(GO:0003285) embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.0 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.4 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.0 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.2 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.0 | 0.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 1.1 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.4 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 1.8 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 2.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 1.3 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.5 | GO:0030282 | bone mineralization(GO:0030282) |
0.0 | 0.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.0 | 0.1 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.0 | 0.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.0 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.0 | 0.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.0 | 0.2 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.0 | 0.8 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.0 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.2 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.0 | 0.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0032208 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.0 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.7 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.2 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
0.0 | 0.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.0 | 0.3 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.0 | 0.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.1 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.0 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.2 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.0 | 0.3 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.0 | 0.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.3 | GO:0048023 | regulation of melanin biosynthetic process(GO:0048021) positive regulation of melanin biosynthetic process(GO:0048023) regulation of secondary metabolite biosynthetic process(GO:1900376) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.2 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.0 | 0.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.2 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.1 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.1 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.0 | 0.1 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 3.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.0 | 0.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.4 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.2 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.2 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.9 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.0 | 0.0 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.3 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.0 | 0.4 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.3 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.0 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.7 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0003166 | bundle of His development(GO:0003166) |
0.0 | 0.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.2 | GO:0046654 | brainstem development(GO:0003360) 'de novo' IMP biosynthetic process(GO:0006189) tetrahydrofolate biosynthetic process(GO:0046654) |
0.0 | 1.2 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.1 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.0 | 0.2 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.0 | 0.3 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.0 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 2.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.1 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.4 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 1.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.1 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.0 | 1.6 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.0 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.2 | GO:0007601 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.1 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.2 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.3 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.0 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.0 | 0.6 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 1.0 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.2 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.2 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0000479 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 1.4 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.6 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.7 | 4.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.4 | 5.3 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.4 | 1.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 0.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.0 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.2 | 1.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 0.6 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
0.2 | 2.8 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 1.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.9 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.2 | 0.7 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.2 | 0.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.2 | 4.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 2.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 1.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 0.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 0.2 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 2.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.6 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 1.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.2 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.1 | 0.2 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.1 | 0.7 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 1.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 3.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 1.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 0.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.0 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.5 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 1.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.0 | 0.3 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 4.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 1.7 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.1 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 1.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 2.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.8 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 1.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 3.6 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.4 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 2.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 1.2 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.0 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.0 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 1.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 2.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.8 | 4.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.5 | 1.5 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
0.4 | 4.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.4 | 2.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 1.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 0.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.3 | 1.4 | GO:0030305 | heparanase activity(GO:0030305) |
0.3 | 1.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.2 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.3 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 0.9 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.3 | 1.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 1.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.2 | 1.4 | GO:0042835 | BRE binding(GO:0042835) |
0.2 | 0.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 1.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 1.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 3.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 1.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 1.3 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.2 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 1.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.2 | 1.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 2.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 0.5 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.2 | 1.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 4.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.9 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.4 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 2.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.5 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.5 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 0.4 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.1 | 0.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 1.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.5 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.8 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.1 | 0.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 1.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.1 | 1.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 1.3 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 1.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 2.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 7.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
0.1 | 0.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.1 | 1.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 2.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 1.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 1.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.3 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.1 | 0.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.3 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.2 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.1 | 0.3 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 0.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.1 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.1 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.4 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.1 | 1.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.0 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.0 | 0.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 1.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 1.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.0 | 0.5 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.9 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.0 | 0.1 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.0 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.3 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 1.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.5 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 1.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 1.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.0 | 8.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 0.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.2 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.0 | 0.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.1 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.0 | 0.0 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.0 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 1.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 1.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 1.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.4 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 1.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 1.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.0 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 1.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.6 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.9 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 1.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.0 | 2.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 5.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 3.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 2.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.0 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 11.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 2.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 1.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 5.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 1.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 3.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 3.9 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 5.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 2.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 4.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 3.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 2.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 4.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 2.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 4.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 1.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 3.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.8 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 1.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 1.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 2.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 2.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 2.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 1.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |